Skip to main content

Table 3 Value distribution of serum CA125 in ovariectomized, non-recurrent, postoperative patients of gynecological malignant tumor

From: Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Type Pathology staging Total CA125 level(U/ml)
I II III IV Range Median X ± S
Fallopian tube cancer 3 7 17 6 33(5.5) 4.1 ~ 12.0 7.4 8.1 ± 2.4
Endometrial cancer 55 88 21 3 167(27.7) 3.1 ~ 15.1 7.0 7.3 ± 2.8
Cervical cancer 152 200 34 17 403(66.8) 3.5 ~ 20.8 6.6 6.7 ± 2.2
Total 210 295 72 26 603(100) 4.1 ~ 20.8 7.2 6.8 ± 2.1